Total Holdings
26
Portfolio diversification across 26 positions
OZEM
(NASDAQ)Roundhill GLP-1 & Weight Loss ETF
$31.85-- (--)
Loading... - Market loading
OZEM ETF Holdings: Roundhill GLP-1 & Weight Loss ETF
Complete portfolio holdings with allocation weights, sector breakdown, and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.
Assets Under Management
$50.27M
Total fund assets
Expense Ratio
0.59%
Annual management fee
Fund Issuer
Roundhill
Nasdaq Stock Market
Portfolio Allocations
Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.
Loading chart...
Top 27 Holdings by Portfolio Weight
View ticker symbols, company names, asset types, and allocation percentages for each position
Scroll to see more
| # | Symbol | Name | Type | Weight |
|---|---|---|---|---|
| 1 |  | Eli Lilly and Company | Stock | 19.26% |
| 2 |  | Novo Nordisk A/S | Stock | 13.13% |
| 3 |  | Pfizer Inc. | Stock | 6.64% |
| 4 |  | Viking Therapeutics Inc | Stock | 4.80% |
| 5 | H HKG:1093 | CSPC Pharmaceutical Group Limited | Stock | 4.50% |
| 6 |  | Kailera Therapeutics, Inc. Common Stock | Stock | 4.44% |
| 7 | T TSE:4519 | Chugai Pharmaceutical Co. Ltd. | Stock | 4.28% |
| 8 | 4 4519.JP | Chugai Pharmaceutical Co Ltd | Stock | 4.22% |
| 9 | C CO:ZEAL | Zealand Pharma A/S | Stock | 4.14% |
| 10 | H HKG:1801 | Innovent Biologics Inc | Stock | 4.00% |
| 11 |  | Amgen Inc. | Stock | 3.81% |
| 12 | Z ZEAL.DC | Zealand Pharma A/S | Stock | 3.77% |
| 13 | K KRX:128940 | Hanmi Pharm. Co., Ltd. | Stock | 3.61% |
| 14 | L LON:AZN | AstraZeneca PLC | Stock | 3.30% |
| 15 |  | Structure Therapeutics Inc. | Stock | 2.92% |
| 16 | S SWX:ROP | Roche Holding AG | Stock | 2.90% |
| 17 |  | MBX Biosciences, Inc. | Stock | 2.73% |
| 18 |  | Regeneron Pharmaceuticals, Inc. | Stock | 2.56% |
| 19 | H HKG:3933 | The United Laboratories International Holdings Limited | Stock | 2.35% |
| 20 | H HKG:1672 | Ascletis Pharma Inc. | Stock | 2.26% |
| 21 | G GUBRA.DC | Gubra A/S | Stock | 2.23% |
| 22 |  | Biohaven Ltd. | Stock | 2.07% |
| 23 |  | Gilead Sciences, Inc. | Stock | 1.69% |
| 24 |  | Rhythm Pharmaceuticals, Inc. | Stock | 1.57% |
| 25 | 4 4507.JP | Shionogi & Co Ltd | Stock | 1.14% |
| 26 |  | Wave Life Sciences Ltd. | Stock | 0.71% |
| 27 |  | Corbus Pharmaceuticals Holdings, Inc. | Stock | 0.25% |
Frequently Asked Questions About Roundhill GLP-1 & Weight Loss ETF Holdings
What are the top holdings in OZEM?
Roundhill GLP-1 & Weight Loss ETF (OZEM) holds 26 securities. View the complete list of top holdings sorted by portfolio weight, showing each security's ticker symbol, company name, asset type, and allocation percentage.
How concentrated is OZEM's portfolio?
Portfolio concentration is measured by the weight of top holdings. A concentrated portfolio has fewer large positions with higher individual weights, while a diversified portfolio distributes holdings more evenly. Review OZEM's holdings table to analyze concentration risk.
What is OZEM's sector allocation?
The Sector Allocation chart shows how OZEM distributes investments across different industries like Technology, Healthcare, Financials, and more. This sector exposure helps understand the fund's industry diversification strategy.
What countries does OZEM invest in?
OZEM's geographic exposure is shown in the Countries tab under Portfolio Allocations. This reveals the fund's international diversification and exposure to different regions and global markets.
How diversified is OZEM ETF?
OZEM's diversification can be assessed by reviewing its 26 holdings, sector allocation, and geographic exposure. A well-diversified ETF spreads investments across multiple securities, sectors, and regions to reduce concentration risk.